Stanford Comprehensive Epilepsy Program News and Events
A new study demonstrates that there are normal physiological responses to cognitive stimuli in non-lesional epileptic tissue unless there is ongoing spontaneous high-frequency oscillation. Josef Parvizi, MD, PhD, professor of neurology and neurological sciences, is quoted in this article.
More than 65 million people around the world are affected by epilepsy. Choosing from over 14,000 different treatment scenarios to decide which drugs might be best for a child or a loved one can be daunting. Robert Fisher, MD, PhD, professor of neurology and neurological sciences at the Stanford University School of Medicine and director of the Stanford Epilepsy Center is the principal investigator of the AI epilepsy trial. The new trial’s goal is to help determine the precision of epilepsy treatment options incorporating many “real world” variables.
Brett’s cross-country bicycling trip from Santa Barbara to South Carolina ended abruptly, 1,000 miles short of its final destination. While crossing through Oklahoma, Brett fell, ending his dreams of completing a coast-to-coast charity ride, and nearly ending his life. Brett spent eight days in the ICU, where a team of trauma and brain injury specialists managed his inter-cranial pressure, blood pressure, temperature and seizures to minimize the cascade of secondary injuries that can occur after a traumatic brain injury.
Transient bursts of high-frequency electrical activity in epileptic brain tissue can impair cognition even when no seizure is occurring, Stanford scientists have found.
The FDA has approved the use of an implanted device that releases periodic electrical discharges in the brain to counteract seizures in people with epilepsy. In an interview, neurologist Robert Fisher described the technology and Stanford’s role in testing the device.
An ongoing project in the Huguenard Lab aims to understand how brain cells regulate their outgoing signals. The lab’s research specifically focuses on a brain structure called the thalamus and its connections — via nerve cells — to the cortex.
Pierre Gloor Award
In June 2018, Robert S. Fisher, MD, PhD, received the Pierre Gloor Award from the Canadian Neurological Sciences Federation. Given to one individual internationally each year who has contributed to clinical EEG and epilepsy research. Dr. Fisher also won an award of the same title in 2008 from the American Society of Clinical Neurophysiology.
Appointed the Chair of the Commission on Medical Therapy for the International League Against Epilepsy (ILAE)
Dr. Kimford J. Meador was appointed the Chair of the Commission on Medical Therapy for the International League Against Epilepsy (ILAE), which is the predominant international organization promoting care and research in epilepsy. The commissions are the main components to forward the goals of the ILAE. The Commission on Medical Therapy is tasked with multiple programs to improve knowledge and use of antiseizure medications.
Caslte Connolly Top Doctor
Robert S. Fisher, MD, PhD, in January 2018, was was selected for TopDocs or Best Doctors in America for the 18th consecutive year.
Kimford J. Meador Research in Women with Epilepsy Award
The American Epilepsy Society named an award after Dr. Meador: “Kimford J. Meador Research in Women with Epilepsy Award.” This award is given to encourage research into special issues faced by women with epilepsy. The award was named after Dr. Meador in recognition of his outstanding contributions in this area.
Laser interstitial thermotherapy (LITT) is safe and effective for treating both gliomas and metastatic brain tumors, including those that are recurrent or deep and inoperable, new research shows.
Sahlie Annual Lecturer
February 2017, Robert S. Fisher, MD, PhD was the Sahlie Annual Lecturer of the University of Alabama at Birmingham. This award is given to one individual each year to serve as a Neurology Grand Rounds lecturer and visiting professor.
Best Abstract Contribution for the 32nd International Epilepsy Congress 2017
Dr. Kimford J. Meador was awarded the Best Abstract Contribution for the 32nd International Epilepsy Congress (2017). Title: “Miscarriages in Pregnant Women with Epilepsy: Findings from the MONEAD Study.” This abstract examined the incidence of miscarriages in pregnant women with epilepsy; this is a rarely investigated problem.